HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Silke Paust Selected Research

Ligands

1/2020Resistance to natural killer cell immunosurveillance confers a selective advantage to polyclonal metastasis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Silke Paust Research Topics

Disease

9Neoplasms (Cancer)
01/2021 - 01/2016
8Infections
01/2024 - 01/2017
6Human Influenza (Influenza)
10/2022 - 12/2010
3Virus Diseases (Viral Diseases)
01/2023 - 01/2017
3Inflammation (Inflammations)
01/2021 - 06/2014
2Alcoholism (Alcohol Abuse)
01/2021 - 01/2020
2Neoplasm Metastasis (Metastasis)
01/2018 - 01/2016
2Contact Dermatitis (Eczema, Contact)
09/2013 - 12/2010
1Communicable Diseases (Infectious Diseases)
01/2023
1Chronic Disease (Chronic Diseases)
01/2021
1Edema (Dropsy)
01/2021
1Weight Loss (Weight Reduction)
01/2021
1Lung Neoplasms (Lung Cancer)
01/2018
1Bites and Stings (Sting)
01/2018
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2018
1Neuroblastoma
11/2017
1Ovarian Neoplasms (Ovarian Cancer)
05/2017
1Ascites
05/2017
1Melanoma (Melanoma, Malignant)
01/2017
1Influenza in Birds (Avian Flu)
01/2017
1Adenocarcinoma
01/2016
1Psoriasis (Pustulosis Palmaris et Plantaris)
06/2014
1Vesicular Stomatitis
12/2010

Drug/Important Bio-Agent (IBA)

10VaccinesIBA
01/2024 - 12/2010
5CytokinesIBA
01/2021 - 05/2017
3Proteins (Proteins, Gene)FDA Link
10/2022 - 01/2017
2Polysaccharides (Glycans)IBA
01/2024 - 04/2023
223-valent pneumococcal capsular polysaccharide vaccineIBA
01/2024 - 04/2023
2Interleukin-15 (Interleukin 15)IBA
01/2023 - 01/2021
2Monoclonal AntibodiesIBA
10/2022 - 01/2021
2Interleukin-10 (Interleukin 10)IBA
01/2021 - 01/2021
2AntibodiesIBA
01/2021 - 01/2017
2Antiviral Agents (Antivirals)IBA
01/2021 - 01/2017
2InterleukinsIBA
05/2017 - 06/2014
1Salivary Proteins and PeptidesIBA
01/2023
1Extracellular Matrix ProteinsIBA
01/2021
1Immune Checkpoint InhibitorsIBA
01/2021
1gamma-Aminobutyric Acid (GABA)IBA
01/2021
1Hemagglutinins (Hemagglutinin)IBA
01/2021
1Neuraminidase (Sialidase)IBA
01/2021
1Peptide Hydrolases (Proteases)FDA Link
01/2021
1Peptides (Polypeptides)IBA
01/2021
1Interleukin-6 (Interleukin 6)IBA
01/2021
1ChemokinesIBA
01/2021
1LigandsIBA
01/2020
1Interleukin-17 (Interleukin 17)IBA
01/2020
1EpitopesIBA
01/2019
1Biomarkers (Surrogate Marker)IBA
01/2018
1Mechanistic Target of Rapamycin Complex 1IBA
11/2017
1RG7388IBA
11/2017
1Drug CombinationsIBA
11/2017
1SuspensionsIBA
11/2017
1temsirolimusFDA Link
11/2017
1Interleukin-2 (IL2)IBA
05/2017
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
05/2017
1Ion Channels (Ion Channel)IBA
01/2017
1Interferon Regulatory FactorsIBA
01/2017
1IpilimumabIBA
01/2016
1GemcitabineFDA Link
01/2016
1Imiquimod (Aldara)FDA LinkGeneric
06/2014
1Interleukin-23 (Interleukin 23)IBA
06/2014
1InterferonsIBA
09/2013
1Interleukin-12 (IL 12)IBA
09/2013
1AntigensIBA
12/2010

Therapy/Procedure

5Immunotherapy
01/2023 - 01/2016
4Therapeutics
01/2021 - 01/2016
1Aftercare (After-Treatment)
11/2017
1Drug Therapy (Chemotherapy)
01/2016